摘要: … Despite initial teething problems, the number of clinically effective monoclonal antibodies is growing. Monoclonal antibodies (mAbs) are nature's biological warheads, able to target …
nature.com
sci-hub.se 参考文章(7)
Dennis A. Carson, Bruce D. Freimark, Human lymphocyte hybridomas and monoclonal antibodies. Advances in Immunology. ,vol. 38, pp. 275- 311 ,(1986) , 10.1016/S0065-2776(08)60009-7
S. L. Morrison, M. J. Johnson, L. A. Herzenberg, V. T. Oi, Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains Proceedings of the National Academy of Sciences of the United States of America. ,vol. 81, pp. 6851- 6855 ,(1984) , 10.1073/PNAS.81.21.6851
Gabrielle L. Boulianne, Nobumichi Hozumi, Marc J. Shulman, Production of functional chimaeric mouse/human antibody Nature. ,vol. 312, pp. 643- 646 ,(1984) , 10.1038/312643A0
J DiMasi, Risks in new drug development: approval success rates for investigational drugs. Clinical Pharmacology & Therapeutics. ,vol. 69, pp. 297- 307 ,(2001) , 10.1067/MCP.2001.115446
G. KÖHLER, C. MILSTEIN, Continuous cultures of fused cells secreting antibody of predefined specificity Nature. ,vol. 256, pp. 495- 497 ,(1975) , 10.1038/256495A0
Peter T. Jones, Paul H. Dear, Jefferson Foote, Michael S. Neuberger, Greg Winter, Replacing the complementarity-determining regions in a human antibody with those from a mouse Nature. ,vol. 321, pp. 522- 525 ,(1986) , 10.1038/321522A0
Janice M Reichert, New biopharmaceuticals in the USA: trends in development and marketing approvals 1995–1999 Trends in Biotechnology. ,vol. 18, pp. 364- 369 ,(2000) , 10.1016/S0167-7799(00)01473-6